Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul;42(7):2611-2614.
doi: 10.1007/s10072-021-05239-6. Epub 2021 Apr 15.

COVID-19-related refractory status epilepticus with the presence of SARS-CoV-2 (RNA) in the CSF: a case report

Affiliations
Case Reports

COVID-19-related refractory status epilepticus with the presence of SARS-CoV-2 (RNA) in the CSF: a case report

Sanaz Ahmadi Karvigh et al. Neurol Sci. 2021 Jul.

Abstract

Amongst the neurologic complications of COVID-19 disease, very few reports have shown the presence of the virus in the cerebrospinal fluid (CSF). Seizure and rarely status epilepticus can be associated with COVID-19 disease. Here we present a 73-year-old male with prior history of stroke who has never experienced seizure before. He had no systemic presentation of COVID-19 disease. The presenting symptoms were two consecutive generalized tonic-clonic seizures that after initial resolution turned into a nonconvulsive status epilepticus despite antiepileptic treatment (a presentation similar to NORSE (new-onset refractory status epilepticus)). There was no new lesion in the brain magnetic resonance imaging (MRI). The CSF analysis only showed an increased protein levels and positive reverse transcription polymerase chain reaction (RT-PCR) of 2019-nCoV. Patient recovered partially after anesthetic, IVIG, steroid, and remdesivir. To our knowledge, this is the first report of a refractory status epilepticus with the presence of SARS-CoV-2 ribonucleic acid (RNA) in the CSF.

Keywords: COVID-19; CSF; Status epilepticus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
a Previous stroke in the left PCA territory with bilateral periventricular white matter lesions. b, c Left temporal cortex flair and DWI hyperintensity
Fig. 2
Fig. 2
a There was very frequent rhythmic (more than 2.5 Hz) left temporal sharp compatible with EEG ictal pattern (starting from: F7> T3, T5)*. b, c There was no posterior dominant rhythm. There was continuous left temporal sharp/periodic lateralized epileptiform discharge (PLED)/EEG ictal pattern (maximum potential: T3, T5) and independent frequent right occipital sharp/PLED (maximum potentialO2)* and a continuous right temporo-occipital rhythmic and irregular delta slowing (maximum potential: O2, T6) which we assumed compatible with focal nonconvulsive status epilepticus. d After tapering the anesthetics, the background rhythm consisted of a low amplitude irregular delta, theta activity without epileptiform discharges. *F frontal, T temporal, O occipital

References

    1. Asadi-Pooya AA, Simani L, Shahisavandi M, Barzegar Z. COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci. 2020;25:1–7. - PMC - PubMed
    1. Sohal S, Mossammat M (2020) COVID-19 presenting with seizures. IDCases:e00782 - PMC - PubMed
    1. Narula N, Joseph R, Katyal N, Daouk A, Acharya S, Avula A, et al. Seizure and COVID-19: association and review of potential mechanism. Neurol Psychiatry Brain Res. 2020;38:49. doi: 10.1016/j.npbr.2020.10.001. - DOI - PMC - PubMed
    1. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70(9):311–322. - PubMed
    1. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi: 10.1016/j.ijid.2020.03.062. - DOI - PMC - PubMed

Publication types